Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Fablife currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is handled by 1 distinct examiner and 1 distinct art unit, showing no current diversification in the company's prosecution efforts. This concentration in 1 distinct art unit suggests that the company's active patent work is focused on a specific technical area. With 1 pending office action, the company can dedicate its full attention to resolving this single matter with the patent office.
BICKHAM, DAWN MARIE is identified as the busiest examiner with 1 busiest examiner pending office action. This examiner oversees the entirety of the portfolio's 1 pending office action, acting as the primary point of contact for the company's pending matters. Since the busiest examiner pending count equals the total number of pending office actions, the decisions of BICKHAM, DAWN MARIE will determine the immediate outcome of the company's patent filings. There are no other distinct examiners or art units currently influencing the prosecution, making this a highly centralized process.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BICKHAM, DAWN MARIE | 1 | 43.9% | +65.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17798768 | METHOD FOR GENERATING A COMPOSITE NUTRITIONAL INDEX, AND ASSOCIATED SYSTEM | BICKHAM, DAWN MARIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17798768 | METHOD FOR GENERATING A COMPOSITE NUTRITIONAL INDEX, AND ASSOCIATED SYSTEM | BICKHAM, DAWN MARIE | — |
| Art Unit | Apps |
|---|---|
| 1685 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17798768 | METHOD FOR GENERATING A COMPOSITE NUTRITIONAL INDEX, AND ASSOCIATED SYSTEM | BICKHAM, DAWN MARIE | 1685 | §101§103 | Non-Final OA | — | Pending | Aug 10, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFablife has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Dawn Marie Bickham has the most, with 1 of Fablife's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
